EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert
K-Number: K230169 · 2023-04-06
Device Summary
Frequently Asked Questions
What is the EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert?
EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert is a medical device that received FDA 510(k) clearance on 2023-04-06. It is manufactured by Encore Medical, L.P Dba Enovis. The 510(k) number is K230169.
When was EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert approved by the FDA?
EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert received FDA 510(k) clearance on 2023-04-06, under approval number K230169.
What company makes EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert?
EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert is manufactured by Encore Medical, L.P Dba Enovis.
What is the FDA product code for EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert?
The FDA product code for EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert is JWH.
Related Clinical Trials
Other Devices by Encore Medical, L.P Dba Enovis
Related Devices (Code: JWH)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.